from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1711/-

LFCtreatmentdescriptionclass of inhibitor

0.540

Amikacinug/mL Amikacintranslation

-0.284

Cap5-10ug/mL Capreomycintranslation

-0.664

Rox10-50 ug/mL Roxithromycintranslation

0.128

SM2-5 ug/mL Streptomycintranslation

0.027

Tet5-10 ug/mL Tetracyclinetranslation

1.144

Rif0.2-5ug/mL Rifampicintranscription

1.426

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.172

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.097

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.227

CPZ10-50 ug/mL Chlorpromazinerespiration

0.944

Clofazimine10-13 ug/mL Clofaziminerespiration

0.484

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.778

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.185

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.071

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.367

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.196

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.478

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.025

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.068

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.770

KCN5-20 ug/mL Potassium cyaniderespiration

-0.402

NaN30.2-2 mM Sodium aziderespiration

-0.548

Nigericin50 uM Nigericinrespiration

1.983

TRC10-150 ug/mL Triclosanrespiration

-0.513

TRZ10-25 ug/mL Thioridazinerespiration

-1.055

Valinomycin0.5-10 uM Valinomycinrespiration

-0.591

ZnSO42 mM ZnSO4respiration

-0.236

menadione6-10 ug/mL Menadionerespiration

-0.409

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.740

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.030

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.491

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.211

NRP_1Non-replicating persistence stage 1dosRassociated

-0.096

Amp0.2mg/mL AmpicillincellWall

-0.466

Cephalexin20-100 ug/mL CephalexincellWall

-0.328

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.562

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.076

EMB10-20 ug/mL EthambutolcellWall

-0.000

Eta12-40 ug/mL EthionamidecellWall

0.203

INH0.2-0.4 ug/mL IsoniazidcellWall

0.458

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.484

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.804

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.636

BZA0.12 mg/mL BenzamidearomaticAmides

0.553

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.279

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.295

H2O24 mM hydrogen peroxideDNAdamaging

0.176

Levo10 ug/mL LevofloxacinDNAdamaging

0.269

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.358

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.750

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.034

UVUV-irradiationDNAdamaging

0.143

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.138

Antimycin12.5-50 ug/mL Antimycin A?

0.148

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.225

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.495

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.365

PA8240.2-2 ug/mL PA-824?

-0.639

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.096

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.366

Verapamil50 uM Verapamil?

-0.196

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.184

methoxatin10-20 ug/mL Methoxatin?